Perrin Megan Wilson serves as Chief Business Officer at Climb Bio, Inc., where they oversee executive responsibilities. Since joining the company, Perrin Megan Wilson has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 6, 2026 involved receiving (via award) 300,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 6, 2026 | CLYM | $0 | Award | 300,000 | $N/A | Discretionary |
Perrin Megan Wilson currently holds 300,000 shares of Climb Bio, Inc. (CLYM), valued at approximately $0. This represents their equity stake as Chief Business Officer.
Based on SEC Form 4 filings, Perrin Megan Wilson has been a net neutral trader of CLYM stock. They have purchased $0 and sold $0 worth of shares.
Perrin Megan Wilson's most recent insider trade was on Jan 6, 2026, when they sold 300,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted